11-108332838-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000051.4(ATM):c.7865C>T(p.Ala2622Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.7865C>T | p.Ala2622Val | missense_variant | Exon 53 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Missense variant that results in aberrant splicing and a null allele in a gene for which loss of function is a known mechanism of disease (Bullrich et al., 1999; Teraoka et al., 1999; Du et al., 2007); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as c.8250C>T; Missense variant that results in aberrant splicing and a null allele in a gene for which loss of function is a known mechanism of disease (Bullrich et al., 1999; Teraoka et al., 1999; Du et al., 2007); This variant is associated with the following publications: (PMID: 24568663, 33624863, 20945614, 16411093, 10330348, 14695534, 24506781, 18321536, 21576124, 17389389, 9892178, 34426522, 32899500) -
ATM: PM2, PS4:Moderate, PP3, PS3:Supporting -
Ataxia-telangiectasia syndrome Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2622 of the ATM protein (p.Ala2622Val). RNA analysis indicates that this missense change induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with ataxia-telangiectasia (PMID: 10330348, 14695534, 16411093, 18321536, 20945614). ClinVar contains an entry for this variant (Variation ID: 449346). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Studies have shown that this missense change results in activation of a cryptic splice site and introduces a premature termination codon (PMID: 10330348, 14695534). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. -
Tip-toe gait Pathogenic:1
Gait disorder -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.7865C>T pathogenic mutation (also known as p.A2622V), located in coding exon 52 of the ATM gene, results from a C to T substitution at nucleotide position 7865. The alanine at codon 2622 is replaced by valine, an amino acid with similar properties. This alteration has been detected in a homozygous state in multiple individuals with Ataxia Telangiectasia (Teraoka SN et al. Am. J. Hum. Genet., 1999 Jun;64:1617-31; Eng L et al. Hum. Mutat., 2004 Jan;23:67-76; Heinrich T et al. Eur. J. Pediatr., 2006 Apr;165:250-7; Aghamohammadi A et al. J Investig Allergol Clin Immunol, 2010;20:442-5). In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. RNA analyses have shown that this alteration creates a new splice donor site, resulting in a deletion of 64 nucleotides from exon 52 and an out of frame transcript (Teraoka SN et al. Am. J. Hum. Genet., 1999 Jun;64:1617-31, Eng L et al. Hum. Mutat., 2004 Jan;23:67-76, Du L et al. Proc. Natl. Acad. Sci. U.S.A., 2007 Apr;104:6007-12, Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at